Another developer of computer-assisted detection systems may be close to entering the market. CADx Medical Systems of Quebec has received an FDA approvable letter for its CAD mammography system. Final approval would clear the way for the company to sell
Another developer of computer-assisted detection systems may be close to entering the market. CADx Medical Systems of Quebec has received an FDA approvable letter for its CAD mammography system. Final approval would clear the way for the company to sell its film-based Second Look product in the U.S. Only the company's combination film digitizer and image report generator would be allowed to enter the U.S. market. Software packages that the company is developing for integration with digital mammography systems from Fischer Imaging and Hologic would not be affected. CADx has been selling Second Look overseas for close to a year. About 25 systems have been installed in more than a dozen countries. List price outside the U.S. is $169,000.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.